Published in J Urol on July 01, 1999
Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. Int J Radiat Oncol Biol Phys (2006) 1.55
Novel diagnostic biomarkers for prostate cancer. J Cancer (2010) 1.36
Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J Cell Biochem (2006) 1.22
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02. Clin Cancer Res (2007) 1.22
Antisense Bcl-2 sensitizes prostate cancer cells to radiation. Prostate (2005) 1.01
Prognostic factors in prostate cancer. Diagn Pathol (2006) 0.99
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202. Int J Radiat Oncol Biol Phys (2007) 0.99
Prognostic determinants in prostate cancer. Cancer J (2011) 0.95
Molecular and genetic prognostic factors of prostate cancer. World J Urol (2003) 0.89
Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases. J Pathol (2013) 0.88
Molecular staging of prostate cancer in the year 2007. World J Urol (2007) 0.85
Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers. Prostate Cancer (2012) 0.84
Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer. BMC Med Genomics (2008) 0.84
The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review. J Cancer Res Clin Oncol (2012) 0.84
Tissue biomarkers for prostate cancer radiation therapy. Curr Mol Med (2012) 0.84
The elevated expression of a mismatch repair protein is a predictor for biochemical recurrence after radical prostatectomy. Cancer Epidemiol Biomarkers Prev (2009) 0.82
Radiosensitization in prostate cancer: mechanisms and targets. BMC Urol (2013) 0.81
Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues. Biomed Res Int (2013) 0.81
Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects? BMC Cancer (2009) 0.80
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer. Front Oncol (2016) 0.79
Molecular targets for radiation oncology in prostate cancer. Front Oncol (2011) 0.78
Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer. Biomed Res Int (2015) 0.77
Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer. World J Urol (2005) 0.76
Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review. Curr Urol Rep (2017) 0.75
Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy. J Cancer Res Clin Oncol (2003) 0.75
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis (2009) 8.37
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry (1999) 5.63
The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci U S A (2001) 5.45
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis (2010) 5.24
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med (2001) 3.39
The Rapunzel syndrome. An unusual complication of intestinal bezoar. Surgery (1968) 3.21
Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol (1995) 2.97
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol (1988) 2.63
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer (1989) 2.62
Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol (2000) 2.51
Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science (1987) 2.50
Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb Drug Resist (1999) 2.35
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A (2000) 2.26
Vascularized iliac crest with internal oblique muscle for immediate reconstruction after maxillectomy. Br J Oral Maxillofac Surg (2002) 2.20
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. Oral Oncol (2006) 2.01
Radial forearm flap donor-site complications and morbidity: a prospective study. Plast Reconstr Surg (1997) 1.96
Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int (2000) 1.93
Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J (1996) 1.93
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis (2010) 1.87
Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer (2006) 1.84
Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol (2003) 1.81
Imaging retinal mosaics in the living eye. Eye (Lond) (2011) 1.81
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Diffusion and convection in normal and neoplastic tissues. Cancer Res (1974) 1.71
Screening for frailty: criteria and predictors of outcomes. J Am Geriatr Soc (1991) 1.65
Spread of the multiresistant Iberian clone of methicillin-resistant Staphylococcus aureus (MRSA) to Italy and Scotland. Microb Drug Resist (1998) 1.62
Effect of intestinal anaphylaxis on gut function in the rat. Gastroenterology (1984) 1.60
Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem (1997) 1.60
Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. . Microb Drug Resist (2000) 1.57
Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin Otolaryngol (2005) 1.55
Human Angiostrongylus cantonensis: an update. Eur J Clin Microbiol Infect Dis (2011) 1.51
Ventricular tachycardias arising from the aortic sinus of valsalva: an under-recognized variant of left outflow tract ventricular tachycardia. J Am Coll Cardiol (2001) 1.50
Mechanism of healing following the Snodgrass repair. J Urol (2001) 1.49
Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis. Acta Haematol (2013) 1.47
Localization of a gene for Duane retraction syndrome to chromosome 2q31. Am J Hum Genet (1999) 1.46
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol (1998) 1.46
Toradol, an NSAID used for renal colic, decreases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruction. J Urol (1993) 1.45
Archaic strains of methicillin-resistant Staphylococcus aureus: molecular and microbiological properties of isolates from the 1960s in Denmark. Microb Drug Resist (2000) 1.44
The influence of hyperbaric oxygen on the outcome of patients treated for osteoradionecrosis: 8 year study. Int J Oral Maxillofac Surg (2007) 1.43
Survival of a free flap after arterial disconnection at six days. Br J Oral Maxillofac Surg (2004) 1.41
Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants. Proc Natl Acad Sci U S A (1996) 1.41
A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb. Mol Endocrinol (1994) 1.41
Adult respiratory distress syndrome after microvascular free tissue reconstruction in head and neck malignancy. Br J Oral Maxillofac Surg (1998) 1.39
A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent. Circ Res (1985) 1.39
Binding of plasminogen to extracellular matrix. J Biol Chem (1986) 1.38
The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R. J Biol Chem (1995) 1.36
SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction. Genes Cells (1996) 1.34
The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry (1998) 1.34
Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol (1999) 1.32
The Cox-Maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg (2000) 1.30
Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med (1983) 1.30
Subcellular localization of the Iitracellular survival-enhancing Eis protein of Mycobacterium tuberculosis. Infect Immun (2001) 1.29
Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Evid Rep Technol Assess (Summ) (2004) 1.27
Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J Gene Med (2000) 1.27
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res (1975) 1.27
Identification of laminin alpha1 and beta1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J (1999) 1.26
Novel receptor interaction and repression domains in the orphan receptor SHP. Mol Cell Biol (1997) 1.26
Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats. J Cereb Blood Flow Metab (1997) 1.22
Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease. Am J Pathol (2001) 1.22
Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int J Oral Maxillofac Surg (1995) 1.22
Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology (1989) 1.21
Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med (1987) 1.20
T4 Bacteriophage-coded RNA polymerase subunit blocks host transcription and unfolds the host chromosome. Nature (1977) 1.20
hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer (2010) 1.19
Health-related quality of life and clinical function after primary surgery for oral cancer. Br J Oral Maxillofac Surg (2002) 1.19
Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term follow-up. Pacing Clin Electrophysiol (2001) 1.18
The influence of prostate size on cancer detection. Urology (1995) 1.18
Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg (2000) 1.18
Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am J Pathol (2001) 1.17
Renal cell carcinoma extending into the inferior vena cava: the prognostic significance of the level of vena caval involvement. J Urol (1984) 1.16
The Charlottesville blood pressure survey: the role of the physician in hypertension case finding. Med Care (1977) 1.16
Genetic study of indirect inguinal hernia. J Med Genet (1994) 1.16
Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J Antimicrob Chemother (1998) 1.15
Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J Neurosci Res (1996) 1.14
Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int (1994) 1.14
Skene's duct cyst in a newborn: case report and review of the literature. J Urol (1977) 1.13
Oral absorption and tolerance in man, of a new penem antibiotic, Sch 29428. J Antimicrob Chemother (1982) 1.13
The Charlottesville Blood-Pressure Survey. Value of repeated blood-pressure measurements. JAMA (1976) 1.13
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. Am J Cardiol (1973) 1.13
Chinese herbal medicine suxiao jiuxin wan for angina pectoris. Cochrane Database Syst Rev (2008) 1.13
Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res (1977) 1.12
Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells. J Biol Chem (1999) 1.12
Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene (1989) 1.11
Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Oncogene (2012) 1.11
Fertile mule in China and her unusual foal. J R Soc Med (1985) 1.11
Familial patent ductus arteriosus. Am J Cardiol (1984) 1.10
Synchronous oral carcinomas: independent or common clonal origin? Cancer Res (1998) 1.10
Isolation and identification of hepatitis E virus in Xinjiang, China. J Gen Virol (1992) 1.09
[Isolation and identification of Leclercia adecarboxylate in clinical isolates in China]. Wei Sheng Wu Xue Bao (1992) 1.09
The effect of indomethacin on renal blood flow and uretral pressure in unilateral ureteral obstruction in a awake dogs. Invest Urol (1978) 1.09
Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology (1992) 1.08
Physiological signals and oncogenesis mediated through Crk family adapter proteins. J Cell Physiol (1998) 1.08
Normal renin secretion in hypertensive patients with primarily unilateral chronic hydronephrosis. J Urol (1974) 1.07